<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0005110'>Atrial fibrillation</z:hpo> (AF) is one of the common <z:hpo ids='HP_0011675'>cardiac arrhythmias</z:hpo> and is responsible for increased mortality and various morbidities </plain></SENT>
<SENT sid="1" pm="."><plain>The prevalence, mortality, morbidity, and treatment strategy for AF might differ between Western countries and Asian countries including Japan </plain></SENT>
<SENT sid="2" pm="."><plain>AF prevalence in elderly subjects (â‰¥ 80 years old) is relatively low in Japan, Korea, and Taiwan as compared with Western countries </plain></SENT>
<SENT sid="3" pm="."><plain>In contrast, the prevalence in mainland China is intermediate between Japan and Western countries </plain></SENT>
<SENT sid="4" pm="."><plain>CHADS(2) score and its new version, CHA(2)DS(2)-VASc score, are useful to predict subsequent <z:hpo ids='HP_0001907'>thromboembolic events</z:hpo> in Japanese AF patients </plain></SENT>
<SENT sid="5" pm="."><plain>Guidelines in Western countries recommend target anticoagulation levels for prevention of thromboembolic and major hemorrhagic events at prothrombin time international normalized ratio (PT-INR) of 2-3 </plain></SENT>
<SENT sid="6" pm="."><plain>However, relatively lower PT-INR levels could be suitable for prevention of these events among patients with nonvalvular AF in Japan and China </plain></SENT>
<SENT sid="7" pm="."><plain>New oral <z:chebi fb="2" ids="50249">anticoagulants</z:chebi> have been launched in Japan as an alternative to <z:chebi fb="8" ids="10033">warfarin</z:chebi> </plain></SENT>
<SENT sid="8" pm="."><plain>The management strategy for AF patients needs to be modified based on the data obtained from Japanese patients </plain></SENT>
</text></document>